Ovarian cancer screening--current status, future directions - Wikidata - wikimedia - TriplyDB

Ovarian cancer screening--current status, future directions

Ovarian cancer screening--current status, future directions

http://www.wikidata.org/entity/Q27004471

about

Emotional and sexual concerns in women undergoing pelvic surgery and associated treatment for gynecologic cancer Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer Methylation of cell-free circulating DNA in the diagnosis of cancer Epidemiology and treatment patterns of epithelial ovarian cancer.Future microfluidic and nanofluidic modular platforms for nucleic acid liquid biopsy in precision medicine.Interleukin 16- (IL-16-) Targeted Ultrasound Imaging Agent Improves Detection of Ovarian Tumors in Laying Hens, a Preclinical Model of Spontaneous Ovarian Cancer.Pilot Clinical Evaluation of a Confocal Microlaparoscope for Ovarian Cancer Detection.Data Mining of Gene Arrays for Biomarkers of Survival in Ovarian Cancer Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers An epidemiologic risk prediction model for ovarian cancer in Europe: the EPIC study.Polarity switching mass spectrometry imaging of healthy and cancerous hen ovarian tissue sections by infrared matrix-assisted laser desorption electrospray ionization (IR-MALDESI)METCAM/MUC18 is a novel tumor and metastasis suppressor for the human ovarian cancer SKOV3 cells Upregulation of miR-572 transcriptionally suppresses SOCS1 and p21 and contributes to human ovarian cancer progression.Modeling the Dynamics of High-Grade Serous Ovarian Cancer Progression for Transvaginal Ultrasound-Based Screening and Early Detection Blood Plasma-Derived Anti-Glycan Antibodies to Sialylated and Sulfated Glycans Identify Ovarian Cancer Patients.Advantages of the avian model for human ovarian cancer Mathematical models of breast and ovarian cancers.Epithelial ovarian carcinoma diagnosis by desorption electrospray ionization mass spectrometry imaging.Upregulation of MiR-205 transcriptionally suppresses SMAD4 and PTEN and contributes to human ovarian cancer progression.Liquid Biopsies for Cancer: Coming to a Patient near You.Psychological and Behavioral Impact of Participation in Ovarian Cancer Screening.Clinical effectiveness of cancer screening biomarker tests offered as self-pay health service: a systematic review.Affective, cognitive and behavioral outcomes associated with a false positive ovarian cancer screening test result.Updates and current challenges in microRNA research for personalized medicine in ovarian cancer.Trends in gynecologic cancer among elderly women in Denmark, 1980-2012.Moving towards population-based genetic risk prediction for ovarian cancer.Anticancer potential of diarylidenyl piperidone derivatives, HO-4200 and H-4318, in cisplatin resistant primary ovarian cancer.High grade serous ovarian carcinomas originate in the fallopian tube.Screening for ovarian cancer: imaging challenges and opportunities for improvement.Nanoscale Coordination Polymers Codeliver Chemotherapeutics and siRNAs to Eradicate Tumors of Cisplatin-Resistant Ovarian Cancer.Demographic, clinical, dispositional, and social-environmental characteristics associated with psychological response to a false positive ovarian cancer screening test: a longitudinal study.Sustaining hope and life courage in patients undergoing ovarian cancer surgery - the impact of care.Pre-clinical evaluation of a themosensitive gel containing epothilone B and mTOR/Hsp90 targeted agents in an ovarian tumor model.Psychological morbidity associated with ovarian cancer screening: results from more than 23,000 women in the randomised trial of ovarian cancer screening (UKCTOCS).Performance of the Risk of Malignancy Index for Discriminating Malignant Tumors in Women With Adnexal Masses.Non-hormonal interruption of incessant ovulation as a potential approach for ovarian cancer prevention.Accuracy of the ADNEX MR scoring system based on a simplified MRI protocol for the assessment of adnexal masses.The Chemoprevention of Ovarian Cancer: the Need and the Options Early identification of recurrence in ovarian cancer: a comparison between the ovarian cancer metastasis index and CA-125 levels

P2860

Q26773707-A83F40B7-508E-47ED-A331-9B44752DE75C Q26780387-7C409C12-EF1D-40E1-91E1-6584944D2D2A Q28085699-B652E655-DD3B-4B14-BDFF-A42E0BBB05E8 Q30235358-8388ED81-409F-42BA-A937-92ABF53D9E68 Q30357091-D8F0D9D8-1F82-4837-8955-6FAD31722E12 Q30407103-2F52098E-2020-489B-8C5F-430323BEDA3A Q30701684-CEB000FB-C176-4D9A-969F-D1BDC478928A Q31126996-241DCE6B-C1A3-4CFE-A771-7C13B385DF56 Q34475484-36835137-5F46-49FE-8C2E-57082C43F9A6 Q35274864-F62B35A3-32D5-4DE1-97EC-B2B95D38462F Q35786609-C83A3E44-6F3A-4D67-A44B-54C185CD3002 Q35932501-BA732CFA-C61D-4A2A-9F73-933263A3D334 Q36020966-395816AB-B7A5-4889-A1D4-1BFAF1A85CC3 Q36039369-9F3D9360-EDC2-4B36-858E-92733B90D9BD Q36169039-F098E78A-03E7-4670-8417-47156775EFD8 Q36334681-B81FF549-1C58-4818-A8DD-1DF34BF1173D Q37014152-E9D03A6D-E908-4513-990C-E68E11EEECDE Q37504535-8C38FAD2-F261-4F0F-8430-5DAB31EB0CF3 Q37618382-756DA435-AAD6-44BD-AECB-A600258DE0FA Q37628173-3D4B3923-5314-4F09-9C63-E13CA54EC1A5 Q37729983-A7F64E77-220C-431F-B491-9ED9365443F9 Q38687692-0E9560EB-6A61-449E-B111-153C793462D6 Q38692120-1DE6C56B-8E54-486F-8E7C-8078544ACE48 Q39391417-B13D0F74-35E1-4622-AF94-1BF1DB51B388 Q40090021-CD0D263E-77F9-42C2-A213-19B664C03EB9 Q40327531-2920BDF4-7A1E-4D53-B7E8-B4BBA59426A9 Q41573533-EBE925B9-7496-41BC-9B28-AA944CF0067B Q42645872-DDF8B3D3-2064-4ADC-892C-57EDFAF6A640 Q43557526-37663E85-29AB-4BED-B1BF-A54923158961 Q46940314-1160C5C9-0FAC-4B60-84E2-3F1E37ACC7F3 Q47288755-554F4278-DBD0-4BF4-A075-80511D4A5C69 Q47608527-46CC3001-9709-4A88-993C-F977DBC0A4F4 Q47619786-F8BCAC0B-381E-4273-968E-50AD9BAAF54D Q47870813-F862830F-FFEF-43A7-8339-F7E570DFDF31 Q50757337-B1E0DE3A-C90F-4E62-A979-9B1E930F5019 Q50880505-C3B4E184-70B3-4BCB-B093-2FED82948A12 Q55015051-484E8F05-5453-4B48-AEFE-3BBEA30E02A8 Q58579152-6F8C0099-23DA-4790-A5F9-1AB3C42AAC6B Q58691005-99725973-651D-4595-960C-3998E71C0B8A

P2860

Ovarian cancer screening--current status, future directions

http://www.wikidata.org/entity/Q27004471

description

2014 nî lūn-bûn

@nan

2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Ovarian cancer screening--current status, future directions

@ast

Ovarian cancer screening--current status, future directions

@en

Ovarian cancer screening--current status, future directions

@nl

type

label

Ovarian cancer screening--current status, future directions

@ast

Ovarian cancer screening--current status, future directions

@en

Ovarian cancer screening--current status, future directions

@nl

prefLabel

Ovarian cancer screening--current status, future directions

@ast

Ovarian cancer screening--current status, future directions

@en

Ovarian cancer screening--current status, future directions

@nl

P1433

Q27004471-0516AF2B-5BBD-4892-9ABC-FF3F3DCC960E

P1476

Q27004471-461969B3-531F-4492-82B9-3EBD9C304914

P2093

Q27004471-A835D7F8-130C-44B1-A62E-E53F2E2B6A1C

P275

Q27004471-2829B330-5803-405F-8B09-FB2CFF3984CC

P2860

Q27004471-05719C67-1826-4A90-8B65-0653977A3A8F

Q27004471-0586A664-4E7A-4964-B803-DEBAA22663B1

Q27004471-0CAB3155-28EC-4706-9F57-6C50F9FFA6E3

Q27004471-0EE3959B-EC5B-4562-A1E0-3540BB8AE299

Q27004471-130B2F5D-F25A-417B-B7F6-1FA00CCB16B1

Q27004471-1DC157C6-3283-4C34-8BBD-A8EFB5FF3989

Q27004471-2A607803-9B58-4366-BCF0-6A9FD741FE25

Q27004471-2B72B5FA-D4D1-4412-8FC6-DD62F8E2AC4B

Q27004471-2EDC6A9D-9B5E-482D-9F0F-ECA5143B5072

Q27004471-2FABC08F-0CA9-4159-951C-73C0DF4ACD30

P304

Q27004471-F4EBA7E4-522A-4368-88AB-FC0D9D5774B5

P31

Q27004471-038B634D-5E95-4D56-8C59-74406A177AB9

Q27004471-CB78A9D8-E7F2-4D61-983B-7B19A2BFDBDF

P3181

Q27004471-8A732538-5DE3-4DCA-87AE-6354A4F647AF

P356

Q27004471-91EF4699-DA32-4C31-91C3-D3EB9457396F

P407

Q27004471-5180A732-E82A-4D7E-B8CE-85FC2D5B54A6

P433

Q27004471-CAC3DA44-0788-4455-85AE-FF5F537E55CE

P478

Q27004471-07448C1C-4008-4CBA-88AB-D4DAA1809E0C

P50

Q27004471-346CDA6C-F894-4A5A-8113-2C4E1B150A78

Q27004471-ECF25C2F-BB65-474A-BEA3-5B81228C2DDA

P5008

Q27004471-90BB52E0-E3C0-477C-8590-5BBF24CE8CAF

P577

Q27004471-42866AB0-221A-407B-AC43-6B2094EF82B3

Q27004471-6402D9D9-772A-42EB-B845-24C17DDC68BD

P5875

Q27004471-3607BC32-C06B-416E-BC32-196BD2AA1BFE

P698

Q27004471-3E9E8D35-1221-4A40-96F8-40C187ABF638

P921

Q27004471-0E436C8A-BF9C-4D39-A4BB-A57502B505DD

Q27004471-3F354A56-C40A-4F5F-A958-0943832E7AB8

P932

Q27004471-FCC0EA68-3CA0-40A8-B55F-9F9EEBD46574

P3181

P356

J.YGYNO.2013.11.030

P1433

Gynecologic Oncology

P1476

Ovarian cancer screening--current status, future directions

@en

P2093

Michelle Griffin

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Impact on mortality and cancer incidence rates of using random invitation from population registers for recruitment to trials

Mathematical model identifies blood biomarker-based early cancer detection strategies and limitations

Effect of Screening on Ovarian Cancer Mortality

The oviduct and ovarian cancer: causality, clinical implications, and "targeted prevention"

Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers

The cell of origin of ovarian epithelial tumours

A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.

A prospective study of risk-reducing salpingo-oophorectomy and longitudinal CA-125 screening among women at increased genetic risk of ovarian cancer: design and baseline characteristics: a Gynecologic Oncology Group study

The preclinical natural history of serous ovarian cancer: defining the target for early detection

Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study

P304

490-5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1057997

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.YGYNO.2013.11.030

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

132

http://www.w3.org/2001/XMLSchema#string

P50

Aleksandra Gentry-Maharaj

P5008

P577

2014-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259246393

http://www.w3.org/2001/XMLSchema#string

P698

24316306

http://www.w3.org/2001/XMLSchema#string

P921

ovarian neoplasm

P932

3991859

http://www.w3.org/2001/XMLSchema#string